<?xml version="1.0" encoding="UTF-8"?>
<p id="P55">The mechanism of action of zanamivir is similar to oseltamivir, by inhibiting neuraminidase, which is essential for release of newly formed viral particles from infected cells.
 <sup>
  <xref ref-type="bibr" rid="R106">106</xref>
 </sup> For treatment, zanamivir is given by inhalation twice daily for 5 days, with the therapy begun within 48 hours after symptom onset. Zanamivir can be given once daily for 10 days as postexposure prophylaxis of influenza A and B in household or close contacts. Zanamivir prophylaxis during community outbreaks may be given for 28 days. Zanamivir has occasionally been given IV to treat critically ill patients with influenza.
 <sup>
  <xref ref-type="bibr" rid="R107">107</xref>,
  <xref ref-type="bibr" rid="R108">108</xref>
 </sup>
</p>
